Drug
Rifabutin clinical trials
Also written Mycobutin.
- studies test it
- 48
- open now
- 3
- in phase 3
- 9
- first study started
- 1994
Keep track of what changes. Save the Rifabutin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
36 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 1 |
| 2003 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 15
- Phase 2
- 10
- Phase 3
- 9
- Phase 4
- 9
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 31
National Institute of Allergy and Infectious Diseases (NIAID) (6) · Pharmacia (6) · Centers for Disease Control and Prevention (5) · ViiV Healthcare (3) · The University of Texas Health Science Center at Tyler (3) · Boehringer Ingelheim (2) · Merck Sharp & Dohme LLC (1) · Shanghai Jiao Tong University School of Medicine (1)
Often tested with
Tested in the same studies.
Clarithromycin (4) · Bedaquiline (3) · Lopinavir-ritonavir drug combination (3) · Rifampin (3) · Azithromycin (3) · Moxifloxacin (2) · Isoniazid (2) · Ritonavir (2)
Studies
Open first, then newest update. How each study uses Rifabutin is read from its arms, and is right about nine times in ten.
Testing it · 48
- The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin ResistanceRecruitingPhase 4National Taiwan University HospitalNCT07514364Written as Rifabutin
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingPhase 2/3The University of QueenslandNCT04310930Written as Rifabutin
- Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIRRecruitingPhase 3Tourcoing HospitalNCT04672525Written as Rifabutin
- Short-course Regimens for the Treatment of Pulmonary TuberculosisActive, not recruitingPhase 2/3Centers for Disease Control and PreventionNCT05766267Written as Rifabutin
- A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)CompletedPhase 1Merck Sharp & Dohme LLCNCT07199452Written as Rifabutin
- Rescue Therapy for Helicobacter Pylori InfectionCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT05874544Written as Rifabutin
- The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy MalesCompletedPhase 1BeiGeneNCT04470908Written as Rifabutin
- Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/IvacaftorCompletedPhase 4University of Southern CaliforniaNCT04840862Written as Rifabutin 300mg
- A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and RifabutinCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT03891901Written as Rifabutin
- The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00001030Written as Rifabutin
- Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000826Written as Rifabutin
- Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000877Written as Rifabutin
- Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart DiseaseTerminatedPhase 2Cadrock Pty. Ltd.NCT03618108Written as Rifabutin Oral Capsule
- Effectiveness of Rifabutin for Treatment of Helicobacter PyloriStatus unknownPhase 3Rabin Medical CenterNCT04652284Written as Rifabutin
- Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.Status unknownPhase 3University of BariNCT04107194Written as Rifabutin 150 MG
- Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy SubjectsCompletedPhase 1ViiV HealthcareNCT03149848Written as Rifabutin
- A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocCompletedPhase 1Ottawa Hospital Research InstituteNCT01894776Written as Rifabutin
- Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice WeeklyCompletedPhase 2The HIV Netherlands Australia Thailand Research CollaborationNCT02415985Written as Rifabutin
- Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.Status unknownPhase 4Konstantopoulio-Patission General Hospital of Nea IoniaNCT04090021Written as Rifabutin 150 MG
- Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With TuberculosisStatus unknownNot applicableShanghai Public Health Clinical CenterNCT03478033Written as Rifabutin
See all 48 studies that test Rifabutin →
Given in every arm · 6 — Rifabutin is usual care beside what is tested
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as Rifabutin
- A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy AdultsCompletedPhase 1ViiV HealthcareNCT07066722Written as Rifabutin
- Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus LevelsTerminatedPhase 1Gilead SciencesNCT05458102Written as Rifabutin
- Assessing PA-824 for Tuberculosis (the APT Trial)CompletedPhase 2Johns Hopkins UniversityNCT02256696Written as Rifabutin
- Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other DrugsCompletedPhase 1ViriomNCT03709355Written as Rifabutin
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedPhase 1University of California, San FranciscoNCT00877591Written as Rifabutin
As the comparator · 1 — what is tested is compared with Rifabutin
Codes
What other systems call Rifabutin · ClinicalTrials.gg INT008615
- MeSH (NLM) D017828RifabutinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1W306TDA6SRIFABUTINConfirmed FDA, NLM, Wikidata
- RxNorm 55672Confirmed FDA, Wikidata
- Wikidata Q1135705rifabutinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1408RifabutinOne source FDA
- DrugBank DB00615One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017828 | Rifabutin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1W306TDA6S | RIFABUTIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 55672 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1135705 | rifabutin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1408 | Rifabutin | One source FDA |
| DrugBank | DB00615 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.